Injective Launches Native EVM Testnet

Injective officially launched its public Ethereum Virtual Machine (EVM) testnet, marking a key breakthrough in its vision to become the ultimate Layer 1 for onchain finance. Unlike traditional add-on EVM solutions or rollups that rely on bridging and third-party infrastructure, Injective’s EVM is natively embedded within its core chain. This innovation reportedly brings unmatched speed, composability, and simplicity to developers and users alike.

Developers can now deploy Solidity-based smart contracts using familiar tools like MetaMask, Foundry, and Remix, while taking full advantage of Injective’s ultra-fast infrastructure, on-chain order book, and native DeFi modules.

Built for High-Speed, Real-World Finance

Injective’s EVM unlocks real performance gains. Benchmarks reveal that the testnet can handle over 800 lightweight transactions per second, or 320 heavy transactions per second while utilizing the full 50 million gas limit per block. With stable block times and parallel execution via advanced account abstraction, developers no longer need to compromise between performance and compatibility.

Per reports, there are no bridges and no external rollups. Everything runs directly on Injective's blockchain, reportedly offering a seamless experience that’s faster, cheaper, and more secure than most EVM alternatives.

MultiVM Architecture Redefines Composability

The launch of Injective’s native EVM is part of its broader MultiVM strategy, which allows both EVM and WASM smart contracts to interact within a single, unified runtime. Developers can build with Solidity while calling into WASM contracts, use shared token standards, and deploy logic that crosses virtual machine boundaries without bridges or duplicated assets.

This unlocks new levels of interoperability. Through the MultiVM Token Standard (MTS), assets and state can be seamlessly shared between EVM and WASM environments. That means a smart contract written in Solidity can interact directly with Injective’s powerful native modules—including central limit order books, frequent batch auctions, and on-chain governance systems.

Injective Powers the Next Generation of DeFi

From tokenized real-world assets to AI-powered trading protocols, the EVM Testnet is already home to an impressive roster of projects:

• Pumex, an advanced DeFi platform focused on yield optimization
• Borderless, enabling pre-TGE token trading across chains
• Meowtrade, a social trading dApp built for Discord communities
• Yei Finance, offering undercollateralized loans and leveraged yield
• Bondi Finance, bridging sovereign bonds to Web3
• Lair Finance, enabling liquid restaking with cross-chain LRTs
• Timeswap v2, offering oracle-free fixed-term lending
• Accumulated Finance, automating asset reallocation for yield
• Stryke, bringing capital-efficient options to DeFi
• Orbiter Finance, connecting Ethereum L2s via a fast cross-rollup bridge

According to the team, Getting started on the Injective EVM testnet requires no seed phrase, no browser extension, and no upfront gas fees. Through its testnet portal, users can create a wallet in seconds and immediately start exploring the ecosystem.

This gasless, signless experience is made possible by account abstraction, which removes one of the biggest onboarding hurdles in Web3. 

Real-World Impact and Market Response

Injective is already powering tokenized stocks, FX pairs, and commodities on-chain—including onchain representations of Oil, Nvidia, and Euros. With native EVM integration, developers can now build even more sophisticated products like structured assets, synthetic markets, and autonomous AI agents directly on Injective.

Investor interest reflects the momentum. Trading volume for Injective’s native token INJ surged by over 79%, while the token is trading at $11.92, up 14% over the last 24 hours/

This EVM launch is a cornerstone of Injective’s long-term roadmap to build the most complete and accessible financial infrastructure in Web3. With the upcoming release of iBuild, a no-code smart contract creation interface, anyone can create, deploy, and scale applications on Injective regardless of technical skill.